Terravitals LoBak

Manufacturer
Terravitals LLC
Effective date
2021-06-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:43:35

Label at a glance#

ProductTerravitals LoBak
Active ingredientPHOSPHORUS, CHAMOMILE, RUTA GRAVEOLENS FLOWERING TOP, VERATRUM ALBUM ROOT, PLATINUM
Label structure10 sections

Storage and handling

Other information: Store in a dry place between 15-30°C (59-86°F) and out of direct sunlight.

Label contents#

Full prescribing information#

Terravitals LoBak Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Drug Facts

Active ingredients

Chamomilla officinalis 6C HPUS

Phosphorus 30C HPUS

Platinum Metallicum 30C HPUS

Ruta graveolens 6C HPUS

Veratrum Album 30C HPUS

'HPUS' indicates that this ingredient is officially included in the Homeopathic Pharmacopoeia of the United States.

Small inner packaging label:

Internal label LoBakInternal label LoBak

Terravitals LoBak Purpose

OTC - PURPOSE SECTION

Active ingredients** ...................................................................... Purpose

Chamomilla officinalis 6C HPUS.................. lumbago and pain in sacrum

Phosphorus 30C HPUS............................................ burning pain in back

Platinum Metallicum 30C HPUS.... spasmodic pain, numbness in coccyx

Ruta graveolens 6C HPUS..................pain in sacrum, lumbar vertebreae

Veratrum album 30C HPUS...................stiffness to sacrum, small of back

'HPUS' indicates that this ingredient is officially included in the Homeopathic Pharmacopoeia of the United States

**'C' is homeopathic dilution.

Uses* For temporary relief of lower back and lumbar pain due to minor muscle strain.

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Terravitals Warnings

WARNINGS SECTION

Warnings Stop use and ask a doctor If symptoms persist more than 5 days or worsen. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

INDICATIONS & USAGE SECTION

Directions: Adults and adolescents 12 and over: Dissolve 1-2 pellets in mouth at the onset of symptoms, repeat every 1- 6 hours as needed

Terravitals Dosage

DOSAGE & ADMINISTRATION SECTION

Oral soluble pellets

Terravitals Other

STORAGE AND HANDLING SECTION

Other information: Store in a dry place between 15-30°C (59-86°F) and out of direct sunlight.

OTC - DO NOT USE SECTION

Do not use if the seal of pellet dispenser inside is missing or broken.

Terravitals Inactive Ingredient

INACTIVE INGREDIENT SECTION

Inactive ingredient Organic Sucrose certified by DE-OKO-070. (Organic logo)

Terravitals LoBak main panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TERRAVITALS LoBak

Homeopathic Medicine

Relieves lower back pain*

NDC 74474-103-01

Approx 75 Oral soluble pellets

Non-drowsy

Not habit-forming

No drug interactions

No known side effects

Made in the USA by Terravitals LLC, Gaithersburg MD 20879

www.terravitals.com

Exp: MM/YYYY

Lot: YYADXX

Outer packaging label:

External label LoBakExternal label LoBak

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
74474-10374474-103-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2b390224-6952-b501-e063-6394a90a6171c4932c78-3de1-f17c-e053-2a95a90a6c732024-08-12WarningsExact identifier
spl set id: c4932c78-3de1-f17c-e053-2a95a90a6c73

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.